Overview
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 26, 2024 | Precision Psychiatry: Circular Genomics Secures $8.3M to Tackle Depression with CircRNA Test | What You Should Know: – Circular Genomics, a pioneer in unlocking the secrets of circular RNA (circRNA) for precision psychiatry and neurology, has secured $8.3 million in a Series A funding round. Led by Mountain Group Partners, this vital... |
| Dec 14, 2021 | Circular Genomics Closes $4.5M Series Seed Investment | November 30, 2021 – Circular Genomics, an Albuquerque, New Mexico-based circRNA company, is pleased to announce the closing of their $4.5M Series Seed investment round. The round was co-led by Cottonwood Technology Fund III and Tramway Vent... |
Reviews 0
FAQ about Tramway Ventures
What has the press written about Tramway Ventures?
Parsers VC has collected 3 articles mentioning Tramway Ventures, among them “Precision Psychiatry: Circular Genomics Secures $8.3M to Tackle Depression with CircRNA Test” (Jan 26, 2024) and “Circular Genomics Closes $4.5M Series Seed Investment” (Dec 14, 2021).
Is Tramway Ventures still active?
Yes, Tramway Ventures is active; its latest activity on Parsers VC dates from Aug 6, 2024.